NewAmsterdam Pharma (NAMS) Revenue (2023 - 2026)
NewAmsterdam Pharma (NAMS) posted Revenue of $3.0 million for Q1 2026, up 9400.0% sequentially from $32000.0 in Q4 2025, and up 2.08% YoY from $3.0 million in Q1 2025.
NewAmsterdam Pharma (NAMS) Revenue (2023 - 2026) Analysis & Trends
NewAmsterdam Pharma has reported Revenue for 4 years, with the latest figure at $3.0 million in Q1 2026.
- Quarterly Revenue rose 2.08% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.6 million (down 52.13% YoY) and the FY2025 annual result came in at $22.5 million, down 50.61% from the prior year.
- Revenue improved to $3.0 million in Q1 2026 per NAMS's latest filing, from $32000.0 in the prior quarter.
- Over five years, Revenue peaked at $29.1 million in Q3 2024 and troughed at $32000.0 in Q4 2025.
- A 4-year average of $6.6 million and a median of $2.9 million in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2024 and 2025: Revenue jumped 1490.54% in 2024, then sank 99.75% in 2025.
- Over 4 years, Revenue stood at $803000.0 in 2023, then surged by 1490.54% to $12.8 million in 2024, then tumbled by 99.75% to $32000.0 in 2025, then surged by 9400.0% to $3.0 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $3.0 million, $32000.0, and $348000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | NewAmsterdam Pharma | 3.17 Bn | 3.17 Bn | - | 3.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.70 Mn |
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 348,000.00 |
| Jun 30, 2025 | 19.15 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Dec 31, 2024 | 12.77 Mn |
| Sep 30, 2024 | 29.11 Mn |
| Jun 30, 2024 | 2.28 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 803,000.00 |
| Sep 30, 2023 | 2.94 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 8.63 Mn |